MNI BRIEF: US Labor Costs Increase 0.9%, Below Expectations

MNI BRIEF: ADP's Richardson Sees Normalizing US Labor Market

CANADA FLASH Q2 GDP ANNUALIZED +2.2%

MNI China Daily Summary: Wednesday, July 31

MNI: PBOC Net Injects CNY185.57 Bln via OMO Wednesday

MNI: PBOC Sets Yuan Parity Lower At 7.1346 Weds; -1.39% Y/Y

MNI: US NAR JUN PENDING HOME SALES INDEX 74.3 V 70.9 IN MAY

MNI Chicago Report™: 17% of Firms Have Sped Up Plans For Holiday Season

MNI Chicago Report™: Around 37% of Respondents See Growth Between 0-5%

RPT-MNI: Canada Sticks To Fiscal Anchors, Spends Chunk Of Windfall

© 1982-2024 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

Extra 200mn Doses Of Pfizer/BioNTech Vaccine Added To EU Order

EU COMMISSION

BioNTech this morning has released a press statement confirming that the European Commission has added an additional 200mn doses of its COVID-19 vaccine to its existing order, with the option of requesting an additional 100mn doses.

  • The order raises the EU's total order of Pfizer/BioNTech vaccines to 500mn to be supplied in 2021, with the firm stating that 75mn are set to be delivered by the end of Q221.
  • The firm also confirms plans to expand production capacity at its plant in Marburg, Germany. This will, according to CEO Dr. Ugur Sahin, allow the firm to produce 2bn doses of its COVID-19 vaccine in 2021.
  • Announcement likely to come as a relief to Commission leadership. President Ursula von der Leyen and her College of Commissioners have faced criticism from all sides over perceptions that it has botched the rollout of the COVID-19 vaccine, and caused major reputational damage to the bloc by seeking to invoke Art.16 of the Northern Ireland protocol to stop the export of vaccines to the UK.
DataHomepagemarkets-real-timePolitical RiskPolitical Risk BulletBulletMarketsFixed Income BulletsForeign Exchange Bullets

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.